Technology

Chinese Smartphone Health Code Rules Post-Virus Life
Worldwide Prides Unite for a Virtual Global Pride This June
Hackers' New Target During Pandemic: Video Conference Calls

Top Story

Worldwide Prides Unite for a Virtual Global Pride This June

Chinese Smartphone Health Code Rules Post-Virus Life

Pride organizations around the world have come together to organize a 'Global Pride' event on Saturday, June 27, 2020, in response to the hundreds of Pride celebrations t...

Worldwide Prides Unite for a Virtual Global Pride This June

Worldwide Prides Unite for a Virtual Global Pride This June

Apr 7
Pride organizations around the world have come together to organize a 'Global Pride' event on Saturday, June 27, 2020, in response to the hundreds of Pride celebrations that have been cancelled or postponed because of the COVID-19 pandemic.

Modeling Coronavirus: 'Uncertainty Is the Only Certainty'

Modeling Coronavirus: 'Uncertainty Is the Only Certainty'

By Seth Borenstein and Carla K. Johnson | Apr 7
A statistical model cited by the White House generated a slightly less grim figure Monday for a first wave of deaths from the coronavirus pandemic. It's almost certainly wrong.

What to Know About Malaria Drug and Coronavirus Treatment

What to Know About Malaria Drug and Coronavirus Treatment

Apr 7
Some politicians and doctors are sparring over whether to use hydroxychloroquine against the new coronavirus, with many scientists saying the evidence is too thin to recommend it now.

Hackers' New Target During Pandemic: Video Conference Calls

Hackers' New Target During Pandemic: Video Conference Calls

By Regina Garcia Cano and Aaron Morrison | Apr 7
Millions have turned to videoconferencing, but many have reported uninvited guests who make threats, interject racist, anti-gay or anti-Semitic messages, or show pornographic images.

Coronavirus Patients Rush to Join Studies of Gilead Drug

Coronavirus Patients Rush to Join Studies of Gilead Drug

By Marilynn Marchione | Apr 6
Coronavirus patients around the world have been rushing to join remdesivir studies that opened in hospitals in the last few weeks.